Actively Recruiting
Observational Study on the Safety and Effectiveness of ConvaNiox Dressing for Diabetic Foot Ulcers
Led by ConvaTec Inc. · Updated on 2026-10-26
102
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the performance and safety of a nitric oxide generating dressing called ConvaNiox in treating diabetic foot ulcers DFUs. This observational study aims to gather real-world evidence on how well this device works and its safety profile for patients with diabetes-related foot ulcers. It is sponsored by ConvaTec Inc. and focuses on adults with type 1 or type 2 diabetes who have specific types of foot ulcers. Participants will receive their standard care for diabetic foot ulcers but will use the ConvaNiox device as their primary dressing instead of their usual one. The study does not involve assigning treatments randomly but observes the outcomes of using this dressing as part of routine care. The device is applied during regular visits, and the study will monitor participants over a period of at least 12 weeks. During the study, participants will undergo assessments including measuring the percentage of ulcer area reduction at 4 and 12 weeks and tracking the incidence of wound closure. Researchers will also evaluate ulcer infections and arterial supply adequacy. Follow-up visits will involve clinical evaluations and data collection to assess the dressings effects, with the main outcome being the percentage of ulcer area reduction after 12 weeks of treatment.
CONDITIONS
Brief Title
Efficacy and Safety of a Nitric Oxide Generating Dressing for Diabetic Foot Ulcers (ONWARD)
Research Team
A
Andrew Thomas
C
Claudia Schroeder
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here